Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
Works of Thomas McRae being referenced
Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies
2016
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas McRae | 1133 | 818 | 382 | 387 | 46 | 2.4k | |
| Ruben Schechter | 1068 | 757 | 265 | 201 | 27 | 3.2k | |
| Kai G. Kahl | 852 | 717 | 209 | 224 | 115 | 3.3k | |
| Suzanne L. Tyas | 1224 | 916 | 92 | 490 | 80 | 3.3k | |
| Francisco Caamaño‐Isorna | 398 | 560 | 217 | 305 | 82 | 3.3k | |
| Francisco J. Díaz | 1367 | 1635 | 340 | 331 | 131 | 4.3k | |
| Emanuele Scafato | 883 | 1237 | 181 | 561 | 95 | 3.9k | |
| Walter M. Bortz | 1554 | 251 | 217 | 389 | 68 | 3.1k | |
| Hissei Imai | 408 | 821 | 1308 | 246 | 79 | 4.4k | |
| Deborah B. Marin | 855 | 1196 | 350 | 309 | 72 | 2.8k | |
| Nicola Coley | 783 | 1253 | 193 | 386 | 83 | 2.6k |
All Works
Loading papers...